Skip to main content

COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV.

Publication ,  Conference
Saloner, R; Marquine, MJ; Sundermann, EE; Hong, S; McCutchan, JA; Ellis, RJ; Heaton, RK; Grant, I; Cherner, M
Published in: J Acquir Immune Defic Syndr
August 15, 2019

OBJECTIVE: The Val allele of the Val158Met single-nucleotide polymorphism of the catechol-o-methyltransferase gene (COMT) results in faster metabolism and reduced bioavailability of dopamine (DA). Among persons living with HIV, Val carriers display neurocognitive deficits relative to Met carriers, presumably due to exacerbation of HIV-related depletion of DA. COMT may also impact neurocognition by modulating cardiometabolic function, which is often dysregulated among persons living with HIV. We examined the interaction of COMT, cardiometabolic risk, and nadir CD4 on neurocognitive impairment (NCI) among HIV+ men. METHODS: Three hundred twenty-nine HIV+ men underwent COMT genotyping and neurocognitive and neuromedical assessments. Cohort-standardized z scores for body mass index, systolic blood pressure, glucose, triglycerides, and high-density lipoprotein cholesterol were averaged to derive a cardiometabolic risk score (CMRS). NCI was defined as demographically adjusted global deficit score of ≥0.5. Logistic regression modeled NCI as a function of COMT, CMRS, and their interaction, covarying for estimated premorbid function, race/ethnicity, and HIV-specific characteristics. Follow-up analysis included the 3-way interaction of COMT, CMRS, and nadir CD4. RESULTS: Genotypes were 81 (24.6%) Met/Met, 147 (44.7%) Val/Met, and 101 (30.7%) Val/Val. COMT interacted with CMRS (P = 0.02) such that higher CMRS increased risk of NCI among Val/Val [odds ratio (OR) = 2.13, P < 0.01], but not Val/Met (OR = 0.93, P > 0.05) or Met/Met (OR = 0.92, P > 0.05) carriers. Among Val/Val, nadir CD4 moderated the effect of CMRS (P < 0.01) such that higher CMRS increased likelihood of NCI only when nadir CD4 <180. DISCUSSION: Results suggest a tripartite model by which genetically driven low DA reserve, cardiometabolic dysfunction, and historical immunosuppression synergistically enhance risk of NCI among HIV+ men, possibly due to neuroinflammation and oxidative stress.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Acquir Immune Defic Syndr

DOI

EISSN

1944-7884

Publication Date

August 15, 2019

Volume

81

Issue

5

Start / End Page

e148 / e157

Location

United States

Related Subject Headings

  • Virology
  • Risk Factors
  • Risk Assessment
  • Polymorphism, Single Nucleotide
  • Odds Ratio
  • Neurocognitive Disorders
  • Middle Aged
  • Metabolic Syndrome
  • Male
  • Immunosuppression Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Saloner, R., Marquine, M. J., Sundermann, E. E., Hong, S., McCutchan, J. A., Ellis, R. J., … Cherner, M. (2019). COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV. In J Acquir Immune Defic Syndr (Vol. 81, pp. e148–e157). United States. https://doi.org/10.1097/QAI.0000000000002083
Saloner, Rowan, Maria J. Marquine, Erin E. Sundermann, Suzi Hong, John Allen McCutchan, Ronald J. Ellis, Robert K. Heaton, Igor Grant, and Mariana Cherner. “COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV.” In J Acquir Immune Defic Syndr, 81:e148–57, 2019. https://doi.org/10.1097/QAI.0000000000002083.
Saloner R, Marquine MJ, Sundermann EE, Hong S, McCutchan JA, Ellis RJ, et al. COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV. In: J Acquir Immune Defic Syndr. 2019. p. e148–57.
Saloner, Rowan, et al. “COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV.J Acquir Immune Defic Syndr, vol. 81, no. 5, 2019, pp. e148–57. Pubmed, doi:10.1097/QAI.0000000000002083.
Saloner R, Marquine MJ, Sundermann EE, Hong S, McCutchan JA, Ellis RJ, Heaton RK, Grant I, Cherner M. COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV. J Acquir Immune Defic Syndr. 2019. p. e148–e157.

Published In

J Acquir Immune Defic Syndr

DOI

EISSN

1944-7884

Publication Date

August 15, 2019

Volume

81

Issue

5

Start / End Page

e148 / e157

Location

United States

Related Subject Headings

  • Virology
  • Risk Factors
  • Risk Assessment
  • Polymorphism, Single Nucleotide
  • Odds Ratio
  • Neurocognitive Disorders
  • Middle Aged
  • Metabolic Syndrome
  • Male
  • Immunosuppression Therapy